Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,589 | -24,487 | -18,555 | -18,638 | -8,470 |
| Depreciation Amortization | 202 | 826 | 614 | 397 | 207 |
| Accounts receivable | N/A | -487 | -419 | N/A | N/A |
| Accounts payable and accrued liabilities | 14 | -338 | -708 | -131 | -314 |
| Other Working Capital | 703 | -1,800 | -1,384 | -307 | -1,693 |
| Other Operating Activity | 1,080 | 7,636 | 6,756 | 3,158 | 1,930 |
| Operating Cash Flow | $-4,590 | $-18,650 | $-13,696 | $-15,521 | $-8,340 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 59,008 | 52,008 | 50,000 | 47,508 |
| PPE Investments | -11 | -482 | -236 | -305 | -10 |
| Purchase Of Investment | N/A | -4,485 | -4,485 | -4,477 | -4,485 |
| Investing Cash Flow | $-11 | $54,041 | $47,287 | $45,218 | $43,013 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -43,754 | -43,754 | -2 | -1 |
| Common Stock Issued | 30,308 | 26,901 | 26,901 | 0 | 0 |
| Other Financing Activity | -28 | -17 | -17 | -17 | -17 |
| Financing Cash Flow | $30,280 | $-16,870 | $-16,870 | $-19 | $-18 |
| Beginning Cash Position | 34,273 | 15,752 | 15,752 | 15,752 | 15,752 |
| End Cash Position | 59,952 | 34,273 | 32,473 | 45,430 | 50,407 |
| Net Cash Flow | $25,679 | $18,521 | $16,721 | $29,678 | $34,655 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,590 | -18,650 | -13,696 | -15,521 | -8,340 |
| Capital Expenditure | -11 | -482 | -236 | -305 | -10 |
| Free Cash Flow | -4,601 | -19,132 | -13,932 | -15,826 | -8,350 |